Clinical Trial Update: NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on haploidentical or matched unrelated donor bone marrow transplantation for newly diagnosed severe aplastic anemia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Severe Aplastic Anemia, Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2022-07-12